These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 11803269)

  • 1. Quantification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in vitro in the urine of healthy controls and stone-forming patients.
    Atmani F; Khan SR
    Urol Int; 2002; 68(1):54-9. PubMed ID: 11803269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects.
    Atmani F; Glenton PA; Khan SR
    Urol Res; 1998; 26(3):201-7. PubMed ID: 9694603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
    Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM
    Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones.
    Khan SR; Glenton PA; Backov R; Talham DR
    Kidney Int; 2002 Dec; 62(6):2062-72. PubMed ID: 12427130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of urinary macromolecules with calcium oxalate crystals induced in vitro in normal human and rat urine.
    Atmani F; Opalko FJ; Khan SR
    Urol Res; 1996; 24(1):45-50. PubMed ID: 8966841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of urine composition and calcium salt crystallization properties in standardized volume-adjusted 12-h night urine from normal subjects and calcium oxalate stone formers.
    Bek-Jensen H; Tiselius HG
    Urol Res; 1997; 25(5):365-72. PubMed ID: 9373919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR
    J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of fluctuations in the composition of renal tubular fluid through the nephron in the initiation of Randall's plugs and calcium oxalate crystalluria in a computer model of renal function.
    Robertson WG
    Urolithiasis; 2015 Jan; 43 Suppl 1():93-107. PubMed ID: 25407799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on crystalluria in calcium oxalate stone formers.
    Ahlstrand C; Tiselius HG; Larsson L
    Urol Res; 1984; 12(2):103-6. PubMed ID: 6539984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion of proteins into calcium oxalate crystals precipitated from human urine: a highly selective phenomenon.
    Doyle IR; Ryall RL; Marshall VR
    Clin Chem; 1991 Sep; 37(9):1589-94. PubMed ID: 1893595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of proteins that inhibit calcium oxalate crystallization in vitro in the urine of normal and stone-forming individuals.
    Hedgepeth RC; Yang L; Resnick MI; Marengo SR
    Am J Kidney Dis; 2001 Jan; 37(1):104-112. PubMed ID: 11136174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An oxalate-binding protein with crystal growth promoter activity from human kidney stone matrix.
    Govindaraj A; Selvam R
    BJU Int; 2002 Aug; 90(3):336-44. PubMed ID: 12133075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for disordered acid-base handling in calcium stone-forming patients.
    Worcester EM; Bergsland KJ; Gillen DL; Coe FL
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F363-F374. PubMed ID: 31790303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.
    Robert M; Boularan AM; Delbos O; Guiter J; Descomps B
    Urol Int; 1998; 60(1):41-6. PubMed ID: 9519420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D; Kalaiselvi P; Varalakshmi P
    Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of warfarin therapy on the charge properties of urinary prothrombin fragment 1 and crystallization of calcium oxalate in undiluted human urine.
    Buchholz NP; Kim DS; Grover PK; Dawson CJ; Ryall RL
    J Bone Miner Res; 1999 Jun; 14(6):1003-12. PubMed ID: 10352110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of a clean face: the effect of different washing procedures on the association of Tamm-Horsfall glycoprotein and other urinary proteins with calcium oxalate crystals.
    Ryall RL; Grover PK; Thurgood LA; Chauvet MC; Fleming DE; van Bronswijk W
    Urol Res; 2007 Feb; 35(1):1-14. PubMed ID: 17277922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of urine dilution on quantity, size and aggregation of calcium oxalate crystals induced in vitro by an oxalate load.
    Guerra A; Allegri F; Meschi T; Adorni G; Prati B; Nouvenne A; Novarini A; Maggiore U; Fiaccadori E; Borghi L
    Clin Chem Lab Med; 2005; 43(6):585-9. PubMed ID: 16006253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.